AIBN research facility BASE hosted an RNA Afternoon on April 7, with Australian experts discussing mRNA therapy advances – and impacts such as on liver disease treatment.
The success of the COVID-19 mRNA vaccines has demonstrated the potential of RNA therapies – and the University of Queensland is driving research and developing facilities to realise the potential.
A pilot facility at AIBN could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.